 |
 |

Controlling Nosocomial Infection
Everyone Is Concerned
Arch Dermatol. 2000;136:785-786.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
IN 1985, a report from the Study on the Efficacy of Nosocomial Infection Control Project,1 a large multicenter surveillance system of nosocomial infections, estimated that at least 2.1 million hospital-acquired infections occurred per year among 37.7 million admissions in US hospitals, and 77,000 deaths were associated with nosocomial infections.2 These data, combined with the concomitant growing emergence of multiresistant bacteria, justified the implementation of infection control policies in hospitals.
Many studies in the field of epidemiology and prevention of nosocomial infections have been conducted in intensive care units (ICUs), which are characterized by the highest rates of nosocomial infections among all hospital facilities. Intensive care units are also where the most severely ill patients are treated and the highest mortality rates occur. The latter occurrence results from the acute severity of illness of patients treated in the ICU, and the rate of nosocomial infection is primarily explained by frequent exposure . . . [Full Text of this Article]
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLE
Methicillin-Resistant Staphylococcus aureus Nosocomial Acquisition and Carrier State in a Wound Care Center
Guillaume Kac, Annie Buu-Hoï, Elisabeth Hérisson, Patricia Biancardini, and Clélia Debure
Arch Dermatol. 2000;136(6):735-739.
ABSTRACT
| FULL TEXT
|